Literature DB >> 8547836

Genetic characteristics of prostate cancer.

M Huncharek1, J Muscat.   

Abstract

Prostate cancer is the most commonly diagnosed malignancy in united States males. Unfortunately, numerous controversies surround clinical management for early stage disease and the utility of population screening. Much of this controversy stems from the lack of knowledge about the biology of prostate cancer, including the lack of clearly defined risk factors, absence of markers indicative of aggressive clinical behavior, as well as a lack of a clear understanding of its underlying genetic features. This paper reviews currently available evidence regarding the genetic characteristics of adenocarcinoma of the prostate, including the impact of family history of disease risk, the nature of structural genetic aberrations, and the possible role of oncogenes and tumor suppressor genes in its pathogenesis. A clearer understanding of these issues will hopefully lead to more effective and rational treatment policies in addition to the development of effective disease prevention strategies.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8547836

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  5 in total

1.  Limitations in the use of race in the study of disease causation.

Authors:  R S Cooper; V L Freeman
Journal:  J Natl Med Assoc       Date:  1999-07       Impact factor: 1.798

2.  Quality of reviews in epidemiology.

Authors:  R A Breslow; S A Ross; D L Weed
Journal:  Am J Public Health       Date:  1998-03       Impact factor: 9.308

3.  Malignant phenotype of PC3 cell line was inhibited by siRNA targeting PAR gene.

Authors:  Xiaofeng Xu; Siwei Zhou; Zhengyu Zhang; Jingping Ge; Wen Cheng; Zhifeng Wei; Xu Zhang; Jianping Gao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-08

4.  c-Myc is a novel target of cell cycle arrest by honokiol in prostate cancer cells.

Authors:  Eun-Ryeong Hahm; Krishna Beer Singh; Shivendra V Singh
Journal:  Cell Cycle       Date:  2016-06-24       Impact factor: 4.534

5.  Prognostic factors in prostate cancer.

Authors:  A Buhmeida; S Pyrhönen; M Laato; Y Collan
Journal:  Diagn Pathol       Date:  2006-04-03       Impact factor: 2.644

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.